Literature DB >> 25189095

Disease activity affects all domains of quality of life in patients with rheumatoid arthritis and is modified by disease duration.

Ying-Ming Chiu1, Mei-Shu Lai, Hsiao-Yi Lin, Hui-Chu Lang, Lukas Jyuhn-Hsiarn Lee, Jung-Der Wang.   

Abstract

OBJECTIVES: This study was conducted to determine how disease activity affects quality of life (QOL) and its interaction with functional impairments, and disease duration in patients with rheumatoid arthritis (RA).
METHODS: This cross-sectional study enrolled 230 patients with RA from a rheumatology clinic in Taiwan and 227 healthy controls matched according to age, sex, marital status, and education. QOL was measured using the Taiwan version of the short form of the World Health Organisation Quality of Life (WHOQOL-BREF) questionnaire. Activity of RA was assessed by the Disease Activity Score in 28 joints using the erythrocyte sedimentation rate (DAS28). Functional disability was assessed by the Health Assessment Questionnaire (HAQ). Multiple regression analyses were performed to explore independent effects and interactions among DAS28, HAQ, and duration after controlling demographic factors.
RESULTS: A higher HAQ score, longer duration of disease, and higher DAS28 score were independently associated with lower QOL scores. DAS28 score affected most items in all physical, psychological, environment, and social domains after controlling other factors. Besides, patients with longer disease duration showed aggravated scores on many facets of the physical and psychological domains, if their disease activity was elevated.
CONCLUSIONS: Disease activity affects QOL of RA patients in all domains. It also aggravates scores in physical and physiological domains among those with a longer duration.

Entities:  

Mesh:

Year:  2014        PMID: 25189095

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

1.  Associations between illness duration and health-related quality of life in specified mental and physical chronic health conditions: results from a population-based survey.

Authors:  Lucy Busija; Jeretine Tan; Kerrie M Sanders
Journal:  Qual Life Res       Date:  2017-05-12       Impact factor: 4.147

2.  Association between disease activity measured by RAPID3 and health-related quality of life in patients with rheumatoid arthritis.

Authors:  Merita Qorolli; Blerta Rexhepi; Sylejman Rexhepi; Matej Mustapić; Ines Doko; Simeon Grazio
Journal:  Rheumatol Int       Date:  2019-03-07       Impact factor: 2.631

3.  Study of Factors Influencing Dry Eye in Rheumatoid Arthritis.

Authors:  Weifang Ma; Guoliang Wang; Xiaofeng Li; Huping Wu; Zuguo Liu; Nuo Dong; Cheng Li
Journal:  J Ophthalmol       Date:  2020-08-08       Impact factor: 1.909

4.  Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.

Authors:  Hye-Lin Kim; Dam Kim; Eun Jin Jang; Min-Young Lee; Hyun Jin Song; Sun-Young Park; Soo-Kyung Cho; Yoon-Kyoung Sung; Chan-Bum Choi; Soyoung Won; So-Young Bang; Hoon-Suk Cha; Jung-Yoon Choe; Won Tae Chung; Seung-Jae Hong; Jae-Bum Jun; Jinseok Kim; Seong-Kyu Kim; Tae-Hwan Kim; Tae-Jong Kim; Eunmi Koh; Hwajeong Lee; Hye-Soon Lee; Jisoo Lee; Shin-Seok Lee; Sung Won Lee; Sung-Hoon Park; Seung-Cheol Shim; Dae-Hyun Yoo; Bo Young Yoon; Sang-Cheol Bae; Eui-Kyung Lee
Journal:  Rheumatol Int       Date:  2016-02-06       Impact factor: 2.631

5.  The impact of co-morbidity on health-related quality of life in rheumatoid arthritis and osteoarthritis patients.

Authors:  Lorie L Geryk; Delesha M Carpenter; Susan J Blalock; Robert F DeVellis; Joanne M Jordan
Journal:  Clin Exp Rheumatol       Date:  2015-03-24       Impact factor: 4.862

6.  Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial.

Authors:  Catalina Gómez-Arango; Inigo Gorostiza; Eduardo Úcar; Maria Luz García-Vivar; Clara Eugenia Pérez; Juan Ramon De Dios; Belen Alvarez; Ana Ruibal-Escribano; Claudia Stoye; Margarida Vasques; Joaquin Belzunegui; Antonio Escobar; Ziortza Trancho; Ainhoa Ruiz Del Agua; Lorena Del Rio; Cristina Jorquera; Eli Diez; Antonio Martínez; Daniel Nagore
Journal:  Rheumatol Ther       Date:  2021-07-18

7.  Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path.

Authors:  Guillermo A Guaracha-Basáñez; Irazú Contreras-Yáñez; Gabriela Hernández-Molina; Viviana A Estrada-González; Lexli D Pacheco-Santiago; Salvador S Valverde-Hernández; José Roberto Galindo-Donaire; Ingris Peláez-Ballestas; Virginia Pascual-Ramos
Journal:  PLoS One       Date:  2022-01-18       Impact factor: 3.240

8.  [Profile and quality of life of patients with rheumatoid arthritis in Guinea Conakry and Cameroon].

Authors:  Aly Badra Kamissoko; Paul Eloundou; Marie Traoré; Mamadou Lamine Diallo; Gervais Mendo; M'balou Fatoumata Diallo; Alhassane Diallo
Journal:  Pan Afr Med J       Date:  2021-04-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.